TFF Pharmaceuticals Inc
NASDAQ:TFFP
TFF Pharmaceuticals Inc
NASDAQ:TFFP
Price:
0.065
USD
Market Closed
Market Cap:
$288.6k
Balance Sheet
Balance Sheet Decomposition
TFF Pharmaceuticals Inc
TFF Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
TFF Pharmaceuticals Inc
TFF Pharmaceuticals Inc
Balance Sheet
TFF Pharmaceuticals Inc
TFF Pharmaceuticals Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
10
|
28
|
35
|
34
|
17
|
5
|
|
| Cash Equivalents |
0
|
0
|
10
|
28
|
35
|
34
|
17
|
5
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
|
| Total Current Assets |
0
|
0
|
10
|
29
|
38
|
39
|
19
|
8
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
2
|
3
|
2
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
10
N/A
|
29
+181%
|
39
+32%
|
41
+5%
|
24
-41%
|
12
-50%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
0
|
1
|
2
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
1
N/A
|
2
+33%
|
1
-14%
|
2
+48%
|
1
-37%
|
2
+98%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
12
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
4
|
16
|
34
|
65
|
97
|
118
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
43
|
72
|
104
|
120
|
128
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
9
N/A
|
28
+199%
|
37
+35%
|
39
+4%
|
23
-41%
|
10
-58%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
10
N/A
|
29
+181%
|
39
+32%
|
41
+5%
|
24
-41%
|
12
-50%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
18
|
18
|
18
|
18
|
23
|
25
|
36
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
